
{
  "drug_name": "Pylera",
  "tradename": "Pylera",
  "usage_and_dosing": {
    "description": "Three-drug combination of bismuth subcitrate potassium, metronidazole, and tetracycline, indicated for use (in combination with omeprazole) for the treatment of adults with H. pylori infection.",
    "capsule_contents": {
      "bismuth_subcitrate_potassium": "140 mg",
      "metronidazole": "125 mg",
      "tetracycline_hcl": "125 mg"
    },
    "adult_dose": {
      "dose": "3 capsules four times a day (after meals and at bedtime) x10 days.",
      "instructions": "Swallow capsules with a full glass of water to reduce risk of esophageal irritation (from tetracycline). Administer with omeprazole 20 mg twice daily."
    },
    "pediatric_dose": [
      {
        "age": ">28 Days",
        "dose": "Safety and efficacy not established"
      }
    ]
  },
  "renal_adjustment": {
    "half_life_normal_function": {
      "bismuth": "120 hrs",
      "metronidazole": "6-14 hrs",
      "tetracycline": "6-12 hrs"
    },
    "half_life_esrd": {
      "bismuth": ">120 hrs",
      "metronidazole": "7-21 hrs",
      "tetracycline": "57-108 hrs"
    },
    "dose_renal_function_normal": "3 caps q6h x10 days",
    "crcl_or_egfr": {
      "crcl_>30": "No dosage adjustment",
      "crcl_<30": "Contraindicated"
    },
    "hemodialysis": "No data",
    "capd": "No data",
    "crrt": "No data",
    "sled": "No data"
  },
  "hepatic_adjustment": {
    "mild_impairment": "No dosage adjustment",
    "moderate_impairment": "No dosage adjustment",
    "severe_impairment": "Use not recommended"
  },
  "adverse_effects": [
    "Aseptic meningitis",
    "Black hairy tongue",
    "Black stools",
    "C. difficile-associated diarrhea",
    "Dizziness",
    "Elevated BUN",
    "Gastrointestinal (nausea, vomiting, diarrhea, abdominal pain)",
    "Hypersensitivity reactions (including SJS, TEN, DRESS)",
    "Intracranial hypertension (including pseudotumor cerebri)",
    "Leukopenia (mild, reversible)",
    "Metallic taste",
    "Neuropathy (optic, peripheral)",
    "Photosensitivity",
    "Teeth discoloration (patients <8 years of age)",
    "Urine discoloration (dark red-brown)",
    "Vaginal candidiasis"
  ],
  "pregnancy_risk": {
    "fda_risk_category": "Contraindicated",
    "use_during_lactation": "Safety not established, avoid use"
  },
  "antimicrobial_spectrum": {
    "preferred": [
      "Helicobacter pylori"
    ],
    "alternative": []
  },
  "pharmacology": {
    "pk_pd_index": {
      "bismuth": "no data",
      "metronidazole": "24-hr AUC/MIC",
      "tetracycline": "24-hr AUC/MIC"
    },
    "pharmaceutical_preparations": "Cap (Bismuth subcitrate K 140 mg, metronidazole 125 mg, tetracycline 125 mg)",
    "food_rec_po_drugs": "Cap after meals, qhs",
    "oral_absorption": {
      "bismuth": "no data",
      "metronidazole": "good",
      "tetracycline": "60-90%"
    },
    "tmax": {
      "bismuth": "no data",
      "metronidazole": "1-2 hrs",
      "tetracycline": "no data"
    },
    "peak_serum_conc": {
      "bismuth": "0.017 (420 mg, SD)",
      "metronidazole": "8.7 (375 mg, SD)",
      "tetracycline": "0.77 (375 mg, SD)"
    },
    "peak_urine_conc": "No data",
    "protein_binding": {
      "bismuth": ">90%",
      "metronidazole": "<20%",
      "tetracycline": "20-65%"
    },
    "volume_of_distribution": {
      "bismuth": "no data",
      "metronidazole": "0.6-0.85 L/kg",
      "tetracycline": "1.3 L/kg"
    },
    "avg_serum_t1_2": {
      "bismuth": "120 hrs",
      "metronidazole": "6-14 hrs",
      "tetracycline": "6-12 hrs"
    },
    "elimination": {
      "bismuth": "biliary, renal",
      "metronidazole": "metabolism, some renal",
      "tetracycline": "biliary, renal"
    },
    "bile_penetration": {
      "bismuth": "no data",
      "metronidazole": "100%",
      "tetracycline": "200-3200%"
    },
    "csf_blood": {
      "bismuth": "no data",
      "metronidazole": "45-89%",
      "tetracycline": "poor"
    },
    "therapeutic_levels_in_csf": {
      "bismuth": "no data",
      "metronidazole": "no data",
      "tetracycline": "no"
    },
    "auc": {
      "bismuth": "0.057 (420 mg, 0-inf)",
      "metronidazole": "84.4 (375 mg, 0-inf)",
      "tetracycline": "10 (375 mg, 0-inf)"
    }
  },
  "enzyme_transporter_mediated_interactions": {
    "cyp450s_inhibited_by_drug": "Metronidazole: CYP2C9"
  },
  "major_drug_interactions": [
    {
      "drug": "Al, Mg, Ca antacids",
      "effect": "↓ tetracycline absorption",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Alcohol",
      "effect": "Disulfiram-like reaction",
      "suggestion": "Contraindicated"
    },
    {
      "drug": "Busulfan",
      "effect": "↑ busulfan",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Disulfiram",
      "effect": "Possible psychotic reactions",
      "suggestion": "Contraindicated"
    },
    {
      "drug": "Iron preparations",
      "effect": "↓ tetracycline absorption",
      "suggestion": "Avoid co-administration"
    },
    {
      "drug": "Lithium",
      "effect": "↑ lithium",
      "suggestion": "Monitor, adjust dosage, or avoid"
    },
    {
      "drug": "Methoxyflurane",
      "effect": "Possible nephrotoxicity",
      "suggestion": "Contraindicated"
    },
    {
      "drug": "Oral contraceptives",
      "effect": "↓ effectiveness of OCs",
      "suggestion": "Use non-hormonal method"
    },
    {
      "drug": "Warfarin",
      "effect": "↑↓ INR",
      "suggestion": "Monitor INR, adjust warfarin dosage"
    },
    {
      "drug": "Zinc preparations",
      "effect": "↓ tetracycline absorption",
      "suggestion": "Avoid co-administration"
    }
  ]
}
